April 20, 2015

Ferring Pharmaceuticals Launches 2015 Heart to Heart Video Contest Supporting Families Who’ve Overcome Infertility

Parents Encouraged to Share Triumph over Infertility for Chance to Win Educational Grants

PARSIPPANY, N.J., April 20, 2015 /PRNewswire-USNewswire/ — Ferring Pharmaceuticals Inc. today announced the launch of its 2015 Heart to Heart Video Contest, coinciding with National Infertility Awareness Week (NIAW). Through the contest, Ferring strives to inspire hope for the millions of Americans affected by infertility, and raise awareness of the disease.

“It is very common for patients to feel that they are facing infertility alone,” said Dr. Grace Couchman of Carolina Conceptions, the fertility center of the 2014 Heart to Heart Video Contest winners. “Initiatives like Ferring’s Heart to Heart Video Contest are important for building a sense of community among families facing infertility and reminding them that they have a support system of those who face similar challenges.”

Parents who enter the 2015 Heart to Heart Video Contest have a chance to win up to $10,000 toward their child’s education. Through August 31, 2015, contestants can submit a creative video that fits the theme “Have Heart, Share Hope,” capturing the story of their journey to parenthood and offering words of support to others facing infertility. Videos can be submitted through the Heart to Heart Video Contest website, www.hearttoheartcontest.com.

Since 2004, Ferring has donated nearly $200,000 to families through similar contests. Now in its third year, the Heart to Heart Video contest has not only helped parents save for their children’s education, but has also advanced efforts to break the silence around the difficult experience of infertility by facilitating the sharing of infertility stories.

“Our infertility journey was a roller coaster, and maintaining hope through the tough times was so important,” said Lisa Park, who along with her husband, James, were winners of the 2014 Heart to Heart Video Contest. “Throughout our experience we’ve learned infertility is more than just one family’s struggle – and we’re appreciative that Ferring gave us the opportunity to speak up, spread hope and offer support to other families facing the diagnosis.”

The deadline for all Heart to Heart Video Contest submissions is August 31, 2015. Entries will be reviewed by a committee of individuals from third-party and patient advocacy organizations from the reproductive health community, who will select the top five finalists. The public will then be invited to vote for their favorite video on www.hearttoheartcontest.com. The video submission with the most votes will win $10,000, while the remaining finalists will each win $4,000 for their child’s education.

To learn more about the Heart to Heart Video Contest, or last year’s winning video and runners up, visit www.hearttoheartcontest.com.

About Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, gastroenterology, infertility, obstetrics/gynecology, orthopaedics, and urology. For more information, call 1-888-FERRING (1-888-337-7464); visit www.FerringUSA.com.

For more information about Ferring Reproductive Health, please visit www.ferringfertility.com.

© 2015 Ferring B.V.                                        4/15                                         RH/597/2015/US

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2000062